stonks

Top House Dem Buys Stock in Pharma Companies and Defense Contractors

by

The Build Back Better Act is in limbo in the U.S. House, with Democratic leaders delaying a vote on the bill on Friday, casting doubt over the fate of provisions added back into the plan that would curb prescription drug costs. In a dramatic late-night decision, Speaker Pelosi allowed a vote on the bipartisan infrastructure […]

From Sludge
On November 9, 2021
Categories

Congress Won’t Stop Trading Stocks

by

Researchers studying congressional stock ownership have found that the practice has effects on lobbying activity and potentially on market movements.

From Sludge
On July 27, 2021
Categories